EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹707 Cr | ₹528 Cr | ₹562 Cr | ₹703 Cr | ₹419 Cr |
What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹707 Cr |
| Mar2024 | ₹528 Cr |
| Mar2023 | ₹562 Cr |
| Mar2022 | ₹703 Cr |
| Mar2021 | ₹419 Cr |
How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹707 Cr | 34.10 | |
| Mar2024 | ₹528 Cr | -6.10 | |
| Mar2023 | ₹562 Cr | -20.03 | |
| Mar2022 | ₹703 Cr | 67.84 | |
| Mar2021 | ₹419 Cr | - | |
Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹29,356.7 Cr | 3.3% | 11.2% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.3% |
11.2% |
15.4% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses